$1.79
0.116.55%
Pre-Market: Jan 28, 9:29 AM EDT
Aytu BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aytu BioPharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2024-11-13 | $-0.20 | $-0.34 | 41.2 % |
Q4 | 2024-09-26 | $-0.82 | $-0.45 | -82.2 % |
Q3 | 2024-05-15 | $-0.52 | $-0.64 | 18.8 % |
Q2 | 2024-02-14 | $-0.04 | $-0.25 | 84.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2024-11-13 | $16.57M | $13.77M | 20.4 % |
Q4 | 2024-09-26 | $17.98M | $18.30M | -1.77 % |
Q3 | 2024-05-15 | $17.99M | $17.35M | 3.71 % |
Q2 | 2024-02-14 | $22.93M | $21.75M | 5.47 % |
Aytu BioPharma (AYTU) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 13, 2024 for Q1.
The Actual EPS was $-0.20, which beat the estimate of $-0.34.
The Actual Revenue was $16.6M, which beat the estimate of $13.8M.
Browse earnings estimates, EPS, and revenue on all stocks.